| Breakdown | Dec 2025 | Dec 2024 | Mar 2024 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 58.88M | -24.28M | -49.47M | -25.59M | -10.19M |
| Gross Profit | 57.27M | -26.08M | -52.84M | -29.19M | -12.89M |
| EBITDA | 36.98M | -60.67M | -64.92M | -42.98M | -27.70M |
| Net Income | 40.52M | -58.79M | -71.69M | -50.78M | -25.92M |
Balance Sheet | |||||
| Total Assets | 481.39M | 437.12M | 488.33M | 652.61M | 704.39M |
| Cash, Cash Equivalents and Short-Term Investments | 10.76M | 38.32M | 95.91M | 125.24M | 76.28M |
| Total Debt | 10.46M | 471.00K | 548.00K | 99.23M | 98.63M |
| Total Liabilities | 24.48M | 21.18M | 13.74M | 108.31M | 112.49M |
| Stockholders Equity | 456.90M | 415.94M | 474.60M | 544.31M | 591.90M |
Cash Flow | |||||
| Free Cash Flow | -37.33M | -56.25M | 55.00K | 49.83M | -85.88M |
| Operating Cash Flow | -37.33M | -55.90M | 482.00K | 49.83M | -85.88M |
| Investing Cash Flow | 0.00 | -344.00K | -427.00K | 0.00 | 0.00 |
| Financing Cash Flow | 9.95M | -297.00K | -28.86M | -305.00K | 97.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | C$101.78B | 33.39 | 41.10% | 3.37% | 597.75% | 50.43% | |
71 Outperform | C$16.11B | 13.28 | 13.03% | 3.59% | -1.02% | -5.65% | |
71 Outperform | C$1.06B | 2.39 | 5.72% | 0.14% | -44.78% | -95.84% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | C$8.07B | 9.04 | 7.20% | 0.36% | 2.46% | -27.48% | |
64 Neutral | ― | 3.93 | -4.35% | ― | -169.96% | 79.35% |